The menace of obesity to depression and anxiety prevalence - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Trends in Endocrinology and Metabolism = Trends in Endocrinology & Metabolism Année : 2022

The menace of obesity to depression and anxiety prevalence

Résumé

The incidence of depression and anxiety is amplified by obesity. Mounting evidence reveals that the psychiatric consequences of obesity stem from poor diet, inactivity, and visceral adipose accumulation. Resulting metabolic and vascular dysfunction, including inflammation, insulin and leptin resistance, and hypertension, have emerged as key risks to depression and anxiety development. Recent research advancements are exposing the important contribution of these different corollaries of obesity and their impact on neuroimmune status and the neural circuits controlling mood and emotional states. Along these lines, this review connects the clinical manifestations of depression and anxiety in obesity to our current understanding of the origins and biology of immunometabolic threats to central nervous system function and behavior.
Fichier principal
Vignette du fichier
NutriNeuro_TrendsEndocrinolMetab_2022_Fulton.pdf (2.22 Mo) Télécharger le fichier
Origine Publication financée par une institution

Dates et versions

hal-03890655 , version 1 (08-12-2022)

Licence

Identifiants

Citer

Stephanie Fulton, Lea Decarie Spain, Xavier Fioramonti, Bruno Guiard, Shingo Nakajima. The menace of obesity to depression and anxiety prevalence. Trends in Endocrinology and Metabolism = Trends in Endocrinology & Metabolism , 2022, 33 (1), pp.18-35. ⟨10.1016/j.tem.2021.10.005⟩. ⟨hal-03890655⟩
59 Consultations
41 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More